Earnings Preview — 1605 total
Gartner heads into its May 5 Q1 results with shorts accelerating hard — and options traders piling on defensively alongside them. Short interest has become the dominant pre-earnings signal. Shares short jumped 21% over…
Emerson Electric reports its fiscal Q2 2026 results on May 5 against a backdrop of analyst target cuts, insider selling, and a stock that has pulled back from its February highs. The options market is actually the…
EMBJ arrives at its May 5 Q1 2026 earnings call having shed nearly half its short interest in the past month — a striking capitulation by the bears just before the print. The short-side retreat is the dominant story in…
Eaton Corporation reports Q1 2026 results on May 5 carrying a 19% one-month price surge that has pushed multiples firmly into elevated territory. Valuation has re-rated sharply on the back of that rally. The P/E has…
DaVita enters its May 5 Q1 2026 earnings report with a notable and consistent insider-selling signal — every transaction logged over the 90-day window has been a sale, not a buy. On March 13, multiple senior executives…
Danaher Corporation heads into its May 5 Q1 report with short sellers meaningfully more active than they were a month ago — a notable shift for a stock where positioning had been quiet. Short interest has nearly…
Cummins heads into its May 5 Q1 earnings call with options positioning at its most cautious level in over a year — just as the stock has staged its biggest monthly rally in recent memory. The options market has turned…
Bristol-Myers Squibb reports Q1 2026 results on May 5 with the stock down 4% on the month and short sellers quietly building pressure into the event. Short interest has climbed sharply over the past week — up more than…
Ball Corporation heads into its May 5 Q1 2026 earnings release with analyst consensus pointing firmly toward upside — yet the stock has only just begun to close the gap. The Street sees meaningful value in BALL at…
Archer-Daniels-Midland heads into its May 5 Q1 2026 earnings call with an interesting split: a stock up 8% on the week and analysts raising targets, while insiders have been consistently cashing out into the…
American Express heads into its May 5 results at a genuine crossroads: the recent Q1 print already rattled investors, and the Street has spent the past three weeks repricing what the next quarter needs to show. Options…
PSKY heads into its May 4 earnings report with short sellers firmly entrenched and options traders tilting toward protection. The short interest story is the dominant setup. At 14.3% of the free float, PSKY sits in the…
ANGX reports Q1 2026 results today against a backdrop of sharp recent losses and a notably bullish options market — a setup that says investors are leaning heavily on a positive surprise to justify the stock's recovery…
Ten-League International Holdings Limited steps into its May 1 earnings report carrying two simultaneous structural changes: full-year results just crossed the wire, and a 1-for-10 reverse share split took effect…
Silynxcom heads into its May 1 earnings release having already dropped a significant result: a full-year EPS of -$0.48 against a $0.13 consensus estimate, with revenues sliding to $5.8 million from $9.1 million a year…
FBLG heads into its May 1 earnings release as one of the most internally-owned small biotech stories in the market — with nearly every C-suite member having bought shares in the open market just weeks ago. The insider…
Healthcare Realty Trust enters its Q1 2026 earnings today with an unusually sharp split between what options positioning implies and what the lending market suggests. The options signal is the loudest indicator into…
Nutex Health reports its Q1 2026 results today carrying one of the more charged setups in small-cap healthcare: a stock that has surged 31% in a single month into a print where more than 13% of the free float is sold…
OPAD approaches its May 4 Q1 results carrying a meaningful short interest position — and one that has been growing fast heading into the release. Short interest has climbed to 11.7% of the free float, up 14% in just…
Summit Therapeutics heads into its May 4 Q1 print riding a sharp reversal — up 26% in a month — while options traders quietly lean more bullish than at almost any point this year. The clearest positioning signal is in…
